Our aim is to stop people dying of bowel cancer. Bowel cancer, also called colorectal cancer (CRC), is the fourth most common cancer and the second most common cancer death in the UK. COLO-SPEED (Colorectal Cancer Screening Prevention Endoscopy and Early Diagnosis), funded by the Sir Bobby Robson Foundation and the Parabola Foundation, is building the world’s largest platform for research in prevention and early diagnosis of bowel cancer.
COLO-SPEED partner site
SCREENING
PREVENTION
ENDOSCOPY
EARLY
DIAGNOSIS
COLO-COHORT recruits 6000 patients
COLO-COHORT
COLO-COHORT aims to develop a “risk stratification tool” to help determine which patients are at highest risk of having polyps or cancer; this tool will be able to be used in the future to work out which patients need to be referred to endoscopy for investigation.
COLO-COHORT aims to develop a “risk stratification tool” to help determine which patients are at highest risk of having polyps or cancer; this tool will be able to be used in the future to work out which patients need to be referred to endoscopy for investigation.
COLO-IT examines how GPs should use a new test, Faecal Immunochemical Test (FIT), to identify which patients with bowel symptoms, are at higher risk of bowel cancer and need to be examined in hospital.
